bpc 157 benefits spine BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven BPC-157: Disc Herniation & Lower

The oral bioavailability means that subcutaneous injection is not the only viable route

The companys founders pled guilty to federal charges in December 2025

No, AOD-9604 is not FDA-approved for human therapeutic use

Contact your healthcare provider if you experience: Bruises larger than two inches in diameter or that continue expanding after 24 hours Severe pain at the injection site that interferes with daily activities or doesn't improve within 48 hours Signs of infection including increasing warmth, redness spreading beyond the immediate injection site, purulent drainage, or fever above 100.4F (38C) Bruising that persists beyond three weeks without improvement Development of a hard lump or nodule beneath the skin that doesn't resolve Sudden increase in bruising frequency or severity compared to your usual pattern Bruising accompanied by unusual bleeding from other sites (gums, nose, or in urine/stool) Patients taking anticoagulant medications require particular vigilance